These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22203922)

  • 1. Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
    Bălăcescu L; Bălăcescu O; Crişan N; Fetica B; Petruţ B; Bungărdean C; Rus M; Tudoran O; Meurice G; Irimie A; Dragoş N; Berindan-Neagoe I
    Rom J Morphol Embryol; 2011; 52(4):1195-202. PubMed ID: 22203922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
    Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
    Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of differentially expressed genes in LNCaP prostate cancer progression model.
    Xie BX; Zhang H; Wang J; Pang B; Wu RQ; Qian XL; Yu L; Li SH; Shi QG; Huang CF; Zhou JG
    J Androl; 2011; 32(2):170-82. PubMed ID: 20864652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.
    Nadiminty N; Dutt S; Tepper C; Gao AC
    Prostate; 2010 Feb; 70(3):276-87. PubMed ID: 19827050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.
    Agell L; Hernández S; Nonell L; Lorenzo M; Puigdecanet E; de Muga S; Juanpere N; Bermudo R; Fernández PL; Lorente JA; Serrano S; Lloreta J
    Am J Pathol; 2012 Nov; 181(5):1585-94. PubMed ID: 23083832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
    Tamura K; Furihata M; Tsunoda T; Ashida S; Takata R; Obara W; Yoshioka H; Daigo Y; Nasu Y; Kumon H; Konaka H; Namiki M; Tozawa K; Kohri K; Tanji N; Yokoyama M; Shimazui T; Akaza H; Mizutani Y; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Jun; 67(11):5117-25. PubMed ID: 17545589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
    Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
    Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
    Stamey TA; Warrington JA; Caldwell MC; Chen Z; Fan Z; Mahadevappa M; McNeal JE; Nolley R; Zhang Z
    J Urol; 2001 Dec; 166(6):2171-7. PubMed ID: 11696729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model.
    Balaji KC; Rao PS; Smith DJ; Louis S; Smith LM; Sherman S; Bacich D; O'Keefe D
    Urol Oncol; 2004; 22(4):313-20. PubMed ID: 15283889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
    Xu J; Stolk JA; Zhang X; Silva SJ; Houghton RL; Matsumura M; Vedvick TS; Leslie KB; Badaro R; Reed SG
    Cancer Res; 2000 Mar; 60(6):1677-82. PubMed ID: 10749139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GREB1 tissue expression is associated with organ-confined prostate cancer.
    Antunes AA; Leite KR; Reis ST; Sousa-Canavez JM; Camara-Lopes LH; Dall'oglio MF; Srougi M
    Urol Oncol; 2012; 30(1):16-20. PubMed ID: 19945309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis for prostate cancer].
    Ueda T; Suzuki H; Ichikawa T
    Nihon Rinsho; 2005 Feb; 63(2):213-7. PubMed ID: 15714968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray-based expression profiling in prostate tumors.
    Elek J; Park KH; Narayanan R
    In Vivo; 2000; 14(1):173-82. PubMed ID: 10757075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer.
    Waghray A; Schober M; Feroze F; Yao F; Virgin J; Chen YQ
    Cancer Res; 2001 May; 61(10):4283-6. PubMed ID: 11358857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of LMO2 expression in the progression of prostate cancer.
    Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
    J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.